| Literature DB >> 28161038 |
Abstract
Pneumonia caused by Rhodococcus equi remains an important cause of disease and death in foals. The combination of a macrolide (erythromycin, azithromycin, or clarithromycin) with rifampin remains the recommended therapy for foals with clinical signs of infection caused by R equi. Most foals with small, subclinical ultrasonographic pulmonary lesions associated with R equi recover without therapy, and administration of antimicrobial agents to these subclinically affected foals does not hasten lesion resolution relative to administration of a placebo. Resistance to macrolides and rifampin in isolates of R equi is increasing.Entities:
Keywords: Macrolide; Pneumonia; Rhodococcus equi; Rifampin
Mesh:
Substances:
Year: 2017 PMID: 28161038 DOI: 10.1016/j.cveq.2016.11.002
Source DB: PubMed Journal: Vet Clin North Am Equine Pract ISSN: 0749-0739 Impact factor: 1.792